Various types of electrochemical biosensors for leukemia detection and therapeutic approaches
S Chupradit, MKM Nasution, HS Rahman… - Analytical …, 2022 - Elsevier
Leukemia often initiates following dysfunctions in hematopoietic stem cells lineages. Various
types of leukemia, including acute lymphoblastic leukemia (ALL), chronic myelogenous …
types of leukemia, including acute lymphoblastic leukemia (ALL), chronic myelogenous …
Acute lymphoblastic leukemia
CH Pui, MV Relling, JR Downing - New England Journal of …, 2004 - Mass Medical Soc
Acute Lymphoblastic Leukemia | New England Journal of Medicine Skip to main content Access
provided by Charite - Universitaetsmedizin Berlin The New England Journal of Medicine …
provided by Charite - Universitaetsmedizin Berlin The New England Journal of Medicine …
Tumor reversion: correction of malignant behavior by microenvironmental cues
PA Kenny, MJ Bissell - International journal of cancer, 2003 - Wiley Online Library
Cancer is characterized by unrestrained proliferation and loss of organization, a process that
is intimately linked to, and controlled by, reciprocal signaling between the genetically altered …
is intimately linked to, and controlled by, reciprocal signaling between the genetically altered …
Philadelphia chromosome–positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in …
CP Soupir, JA Vergilio, PD Cin… - American journal of …, 2007 - academic.oup.com
We performed a multi-institutional retrospective analysis of the morphologic features,
immunophenotype, cytogenetics, and BCR-ABL transcript characterization of cases of …
immunophenotype, cytogenetics, and BCR-ABL transcript characterization of cases of …
Molecular processes involved in B cell acute lymphoblastic leukaemia
C Malouf, K Ottersbach - Cellular and molecular life sciences, 2018 - Springer
B cell leukaemia is one of the most frequent malignancies in the paediatric population, but
also affects a significant proportion of adults in developed countries. The majority of infant …
also affects a significant proportion of adults in developed countries. The majority of infant …
Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets
S Adnan-Awad, D Kim, H Hohtari, KK Javarappa… - Leukemia, 2021 - nature.com
Abstract The oncogenic protein Bcr-Abl has two major isoforms, p190Bcr-Abl and p210Bcr-
Abl. While p210Bcr-Abl is the hallmark of chronic myeloid leukemia (CML), p190Bcr-Abl …
Abl. While p210Bcr-Abl is the hallmark of chronic myeloid leukemia (CML), p190Bcr-Abl …
Phasing analysis of lung cancer genomes using a long read sequencer
Y Sakamoto, S Miyake, M Oka, A Kanai… - Nature …, 2022 - nature.com
Chromosomal backgrounds of cancerous mutations still remain elusive. Here, we conduct
the phasing analysis of non-small cell lung cancer specimens of 20 Japanese patients. By …
the phasing analysis of non-small cell lung cancer specimens of 20 Japanese patients. By …
ABL1 fusion genes in hematological malignancies: a review
E De Braekeleer, N Douet‐Guilbert… - European journal of …, 2011 - Wiley Online Library
Chromosomal rearrangements involving the ABL1 gene, leading to a BCR‐ABL1 fusion
gene, have been mainly associated with chronic myeloid leukemia and B‐cell acute …
gene, have been mainly associated with chronic myeloid leukemia and B‐cell acute …
Differential Gene Expression Patterns and Interaction Networks in BCR-ABL–Positive and –Negative Adult Acute Lymphoblastic Leukemias
D Juric, NJ Lacayo, MC Ramsey… - Journal of clinical …, 2007 - ascopubs.org
Purpose To identify gene expression patterns and interaction networks related to BCR-ABL
status and clinical outcome in adults with acute lymphoblastic leukemia (ALL). Patients and …
status and clinical outcome in adults with acute lymphoblastic leukemia (ALL). Patients and …
Optimizing T-cell receptor gene therapy for hematologic malignancies
EC Morris, HJ Stauss - Blood, The Journal of the American …, 2016 - ashpublications.org
Recent advances in genetic engineering have enabled the delivery of clinical trials using
patient T cells redirected to recognize tumor-associated antigens. The most dramatic results …
patient T cells redirected to recognize tumor-associated antigens. The most dramatic results …